Gitman Paul

Avg. Two Year Performance

No purchase track record
(10%) Avg. Sale Return
(5%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(11%)(8%)(3%)1%(10%)
Sale Success Rate6 of 113 of 113 of 114 of 112 of 11
Drugs » Biotechnology

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--